Page 4 of 9 – SEC Filing
| SCHEDULE 13D | ||
| CUSIP No. 00547W208 | Page 4 of 9 |
This Amendment
No. 11 (this “Amendment No. 11”) amends and restates the Schedule 13D originally filed with the United States
Securities and Exchange Commission (the “SEC”) by Ahmed Shayan Fazlur Rahman and Eses Holdings (FZE) on November
22, 2010, and amended by Amendment No. 1 thereto filed on July 5, 2011, Amendment No. 2 thereto filed on July 26, 2011, Amendment
No. 3 thereto filed on November 21, 2011, Amendment No. 4 thereto filed on February 3, 2012, Amendment No. 5 thereto filed on July
30, 2013, Amendment No. 6 thereto filed on December 24, 2013, Amendment No. 7 thereto filed on June 16, 2014, Amendment No. 8 thereto
filed on February 17, 2015, Amendment No. 9 thereto filed on April 14, 2016 and Amendment No. 10 thereto filed on August 29, 2016
(as so amended, the “Statement”) relating to the shares of common stock, $0.0001 par value per share (the “Common
Stock”), of Adamis Pharmaceuticals Corporation, a Delaware corporation (the “Company”). This Amendment
No. 11 reflects changes to Items 5 and 7 of the Statement.
The Reporting
Persons, as defined below, are filing this Amendment No. 11 to report the change in their beneficial ownership of Common Stock
solely due to an increase in the number of Common Stock outstanding.
| Item 1. | Security and Issuer |
This statement on Schedule 13D relates to
the common stock, $0.0001 par value per share, of Adamis Pharmaceuticals Corporation, a Delaware corporation, beneficially owned
by the Reporting Persons. The Company’s principal executive office is located at: 11682 El Camino Real, Suite 300, San Diego, CA
92130.
| Item 2. | Identity and Background |
(a) This Schedule 13D
is being filed on behalf of (i) Eses Holdings (FZE), a limited liability free zone establishment formed in accordance with the
laws of Sharjah, United Arab Emirates (“Eses”) and (ii) Ahmed Shayan Fazlur Rahman, a citizen of the United
Kingdom (“Mr. Rahman”). Eses is the owner of the Common Stock reported herein. Mr. Rahman controls Eses, of
which he is the sole shareholder, and, accordingly, he may be deemed to beneficially own those shares of Common Stock owned by
Eses. Eses and Mr. Rahman are collectively referred to herein as the “Reporting Persons.”
(b), (c) and (f)
(i) The address of
Eses’ principal place of business is Sharjah Airport Free Zone, Executive Suite, P.O. Box 9366, Sharjah, United Arab Emirates.
The principal business of Eses is to act as a holding company. Mr. Rahman is the sole officer and director of Eses.
(ii) Mr. Rahman is
a citizen of the United Kingdom, and his present principal occupation is to act as owner and manager of Eses. Mr. Rahman’s
address is c/o Eses Holdings (FZE), Sharjah Airport Free Zone, Executive Suite, P.O. Box 9366, Sharjah, United Arab Emirates.
(d) During the last
five years, neither of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors).
(e) During the last
five years, neither of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations
of, or prohibiting or mandating activities subject to, federal or state securities laws, or finding any violation with respect
to such laws.
